Development programs

Immune Mediated Disorders

RA-INF-Dx

RA-INF-Dx is a non invasive multigene  diagnostic blood test intended to aid in the identification of RA patients for whom the combination Infliximab and MTX is being considered.

Development Status: External validation and prospective clinical trial on going.

IMD Dx2

IMD Dx2 is a non invasive multigene molecular diagnostic blood test intended to aid in the identification of RA patients for whom an anti-TNF other than Infliximab or another biologic is being considered.

Development Status: ongoing genomic signature discovery process.

IMD Dx3

IMD Dx3 is a non invasive multigene molecular diagnostic blood test.

Development Status: ongoing genomic signature discovery process

Transplantation

L-TolX

The L-TolX test is a qualitative diagnostic test service using the gene expression profiling of mRNA. The L-TolX test is an in vitro diagnostic test intended to aid in the identification of liver transplant recipients with stable allograft function for whom immunosuppression withdrawal is being considered.

Development Status: First prospective clinical trial completed / product ready for partnership in 2011

Comments are closed.